EMEA (Europe, Middle East and Africa) Newcastle Disease Vaccine Market Report 2017

November 2017 | 117 pages | ID: E3DC285AD3FEN
QYResearch

Abstracts

In this report, the EMEA Newcastle Disease Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (M Doses), revenue (Million USD), market share and growth rate of Newcastle Disease Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Newcastle Disease Vaccine market competition by top manufacturers/players, with Newcastle Disease Vaccine sales volume (M Doses), price (USD/K Doses), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merial
• CEVA
• QYH Biotech
• Ringpu Biology
• Yebio
• Harbin Veterinary Research Institute
• Merck Animal Health
• DHN
• Zoetis
• ChengDu Tecbond
• Elanco (Lohmann)
• FATRO
• CAVAC
• Vaksindo

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Live Vaccines
• Killed Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Chicken
• Duck & Goose
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Newcastle Disease Vaccine Market Report 2017

1 NEWCASTLE DISEASE VACCINE OVERVIEW

1.1 Product Overview and Scope of Newcastle Disease Vaccine
1.2 Classification of Newcastle Disease Vaccine
  1.2.1 EMEA Newcastle Disease Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Newcastle Disease Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Live Vaccines
  1.2.4 Killed Vaccines
1.3 EMEA Newcastle Disease Vaccine Market by Application/End Users
  1.3.1 EMEA Newcastle Disease Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Chicken
  1.3.3 Duck & Goose
  1.3.4 Other
1.4 EMEA Newcastle Disease Vaccine Market by Region
  1.4.1 EMEA Newcastle Disease Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Newcastle Disease Vaccine (2012-2022)
  1.5.1 EMEA Newcastle Disease Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Newcastle Disease Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA NEWCASTLE DISEASE VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Newcastle Disease Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Newcastle Disease Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Newcastle Disease Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Newcastle Disease Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Newcastle Disease Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Newcastle Disease Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Newcastle Disease Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Newcastle Disease Vaccine (Volume) by Application
2.4 EMEA Newcastle Disease Vaccine (Volume and Value) by Region
  2.4.1 EMEA Newcastle Disease Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Newcastle Disease Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Newcastle Disease Vaccine Sales Price by Region (2012-2017)

3 EUROPE NEWCASTLE DISEASE VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Newcastle Disease Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Newcastle Disease Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Newcastle Disease Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Newcastle Disease Vaccine Sales and Market Share by Type
3.3 Europe Newcastle Disease Vaccine Sales and Market Share by Application
3.4 Europe Newcastle Disease Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Newcastle Disease Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Newcastle Disease Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NEWCASTLE DISEASE VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Newcastle Disease Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Newcastle Disease Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Newcastle Disease Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Newcastle Disease Vaccine Sales and Market Share by Type
4.3 Middle East Newcastle Disease Vaccine Sales and Market Share by Application
4.4 Middle East Newcastle Disease Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Newcastle Disease Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Newcastle Disease Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA NEWCASTLE DISEASE VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Newcastle Disease Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Newcastle Disease Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Newcastle Disease Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Newcastle Disease Vaccine Sales and Market Share by Type
5.3 Africa Newcastle Disease Vaccine Sales and Market Share by Application
5.4 Africa Newcastle Disease Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Newcastle Disease Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Newcastle Disease Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Newcastle Disease Vaccine Sales and Growth Rate (2012-2017)

6 EMEA NEWCASTLE DISEASE VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merial
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CEVA
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 QYH Biotech
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Ringpu Biology
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Yebio
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Harbin Veterinary Research Institute
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Merck Animal Health
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 DHN
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Zoetis
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 ChengDu Tecbond
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Newcastle Disease Vaccine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Elanco (Lohmann)
6.12 FATRO
6.13 CAVAC
6.14 Vaksindo

7 NEWCASTLE DISEASE VACCINE MANUFACTURING COST ANALYSIS

7.1 Newcastle Disease Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Newcastle Disease Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Newcastle Disease Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Newcastle Disease Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NEWCASTLE DISEASE VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Newcastle Disease Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Newcastle Disease Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Newcastle Disease Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Newcastle Disease Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Newcastle Disease Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Newcastle Disease Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Newcastle Disease Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Newcastle Disease Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Newcastle Disease Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Newcastle Disease Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Newcastle Disease Vaccine
Figure EMEA Newcastle Disease Vaccine Sales Volume (M Doses) by Type (2012-2022)
Figure EMEA Newcastle Disease Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Live Vaccines Product Picture
Figure Killed Vaccines Product Picture
Figure EMEA Newcastle Disease Vaccine Sales Volume (M Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Newcastle Disease Vaccine by Application in 2016
Figure Chicken Examples
Table Key Downstream Customer in Chicken
Figure Duck & Goose Examples
Table Key Downstream Customer in Duck & Goose
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Newcastle Disease Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Newcastle Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Newcastle Disease Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Newcastle Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Newcastle Disease Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Newcastle Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Newcastle Disease Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Newcastle Disease Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Newcastle Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Newcastle Disease Vaccine Market Major Players Product Sales Volume (M Doses) (2012-2017)
Table EMEA Newcastle Disease Vaccine Sales Volume (M Doses) of Major Players (2012-2017)
Table EMEA Newcastle Disease Vaccine Sales Share by Players (2012-2017)
Figure 2016 Newcastle Disease Vaccine Sales Share by Players
Figure 2017 Newcastle Disease Vaccine Sales Share by Players
Figure EMEA Newcastle Disease Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Newcastle Disease Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Newcastle Disease Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Newcastle Disease Vaccine Revenue Share by Players
Table 2017 EMEA Newcastle Disease Vaccine Revenue Share by Players
Table EMEA Newcastle Disease Vaccine Sale Price (USD/K Doses) by Players (2012-2017)
Table EMEA Newcastle Disease Vaccine Sales (M Doses) and Market Share by Type (2012-2017)
Table EMEA Newcastle Disease Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Newcastle Disease Vaccine by Type (2012-2017)
Figure EMEA Newcastle Disease Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Newcastle Disease Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Newcastle Disease Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Newcastle Disease Vaccine by Type in 2016
Table EMEA Newcastle Disease Vaccine Sale Price (USD/K Doses) by Type (2012-2017)
Table EMEA Newcastle Disease Vaccine Sales (M Doses) and Market Share by Application (2012-2017)
Table EMEA Newcastle Disease Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Newcastle Disease Vaccine by Application (2012-2017)
Figure EMEA Newcastle Disease Vaccine Sales Market Share by Application in 2016
Table EMEA Newcastle Disease Vaccine Sales (M Doses) and Market Share by Region (2012-2017)
Table EMEA Newcastle Disease Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Newcastle Disease Vaccine by Region (2012-2017)
Figure EMEA Newcastle Disease Vaccine Sales Market Share in 2016
Table EMEA Newcastle Disease Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Newcastle Disease Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Newcastle Disease Vaccine by Region (2012-2017)
Figure EMEA Newcastle Disease Vaccine Revenue Market Share Regions in 2016
Table EMEA Newcastle Disease Vaccine Sales Price (USD/K Doses) by Region (2012-2017)
Figure Europe Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Europe Newcastle Disease Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Newcastle Disease Vaccine Sales (M Doses) by Type (2012-2017)
Table Europe Newcastle Disease Vaccine Market Share by Type (2012-2017)
Figure Europe Newcastle Disease Vaccine Market Share by Type in 2016
Table Europe Newcastle Disease Vaccine Sales (M Doses) by Application (2012-2017)
Table Europe Newcastle Disease Vaccine Market Share by Application (2012-2017)
Figure Europe Newcastle Disease Vaccine Market Share by Application in 2016
Table Europe Newcastle Disease Vaccine Sales (M Doses) by Countries (2012-2017)
Table Europe Newcastle Disease Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Newcastle Disease Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Newcastle Disease Vaccine Sales Market Share by Countries in 2016
Table Europe Newcastle Disease Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Newcastle Disease Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Newcastle Disease Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Newcastle Disease Vaccine Revenue Market Share by Countries in 2016
Figure Germany Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure France Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure UK Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Russia Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Italy Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Benelux Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Middle East Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Middle East Newcastle Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Newcastle Disease Vaccine Sales (M Doses) by Type (2012-2017)
Table Middle East Newcastle Disease Vaccine Market Share by Type (2012-2017)
Figure Middle East Newcastle Disease Vaccine Market Share by Type (2012-2017)
Table Middle East Newcastle Disease Vaccine Sales (M Doses) by Applications (2012-2017)
Table Middle East Newcastle Disease Vaccine Market Share by Applications (2012-2017)
Figure Middle East Newcastle Disease Vaccine Sales Market Share by Application in 2016
Table Middle East Newcastle Disease Vaccine Sales Volume (M Doses) by Countries (2012-2017)
Table Middle East Newcastle Disease Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Newcastle Disease Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Newcastle Disease Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Newcastle Disease Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Newcastle Disease Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Newcastle Disease Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Israel Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure UAE Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Iran Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Africa Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Africa Newcastle Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Newcastle Disease Vaccine Sales (M Doses) by Type (2012-2017)
Table Africa Newcastle Disease Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Newcastle Disease Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Newcastle Disease Vaccine Sales Market Share by Type in 2016
Table Africa Newcastle Disease Vaccine Sales (M Doses) by Application (2012-2017)
Table Africa Newcastle Disease Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Newcastle Disease Vaccine Sales Market Share by Application (2012-2017)
Table Africa Newcastle Disease Vaccine Sales Volume (M Doses) by Countries (2012-2017)
Table Africa Newcastle Disease Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Newcastle Disease Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Newcastle Disease Vaccine Sales Market Share by Countries in 2016
Table Africa Newcastle Disease Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Newcastle Disease Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Newcastle Disease Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Newcastle Disease Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Nigeria Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Egypt Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Algeria Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Table Merial Newcastle Disease Vaccine Basic Information List
Table Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure Merial Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Merial Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merial Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table CEVA Newcastle Disease Vaccine Basic Information List
Table CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure CEVA Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure CEVA Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure CEVA Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table QYH Biotech Newcastle Disease Vaccine Basic Information List
Table QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure QYH Biotech Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure QYH Biotech Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure QYH Biotech Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table Ringpu Biology Newcastle Disease Vaccine Basic Information List
Table Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure Ringpu Biology Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Ringpu Biology Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure Ringpu Biology Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table Yebio Newcastle Disease Vaccine Basic Information List
Table Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure Yebio Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Yebio Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure Yebio Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table Harbin Veterinary Research Institute Newcastle Disease Vaccine Basic Information List
Table Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table Merck Animal Health Newcastle Disease Vaccine Basic Information List
Table Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure Merck Animal Health Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Merck Animal Health Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merck Animal Health Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table DHN Newcastle Disease Vaccine Basic Information List
Table DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure DHN Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure DHN Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure DHN Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table Zoetis Newcastle Disease Vaccine Basic Information List
Table Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure Zoetis Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure Zoetis Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure Zoetis Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table ChengDu Tecbond Newcastle Disease Vaccine Basic Information List
Table ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2012-2017)
Figure ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses) and Growth Rate (2012-2017)
Figure ChengDu Tecbond Newcastle Disease Vaccine Sales Market Share in EMEA (2012-2017)
Figure ChengDu Tecbond Newcastle Disease Vaccine Revenue Market Share in EMEA (2012-2017)
Table Elanco (Lohmann) Newcastle Disease Vaccine Basic Information List
Table FATRO Newcastle Disease Vaccine Basic Information List
Table CAVAC Newcastle Disease Vaccine Basic Information List
Table Vaksindo Newcastle Disease Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Newcastle Disease Vaccine
Figure Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure Newcastle Disease Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Newcastle Disease Vaccine Major Manufacturers in 2016
Table Major Buyers of Newcastle Disease Vaccine
Table Distributors/Traders List
Figure EMEA Newcastle Disease Vaccine Sales (M Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Newcastle Disease Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Newcastle Disease Vaccine Price (USD/K Doses) and Trend Forecast (2017-2022)
Table EMEA Newcastle Disease Vaccine Sales (M Doses) Forecast by Region (2017-2022)
Figure EMEA Newcastle Disease Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Newcastle Disease Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Newcastle Disease Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Newcastle Disease Vaccine Sales (M Doses) Forecast by Countries (2017-2022)
Figure Europe Newcastle Disease Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Newcastle Disease Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Newcastle Disease Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Newcastle Disease Vaccine Sales (M Doses) Forecast by Countries (2017-2022)
Figure Middle East Newcastle Disease Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Newcastle Disease Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Newcastle Disease Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Newcastle Disease Vaccine Sales (M Doses) Forecast by Countries (2017-2022)
Figure Africa Newcastle Disease Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Newcastle Disease Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Newcastle Disease Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Newcastle Disease Vaccine Sales (M Doses) Forecast by Type (2017-2022)
Figure EMEA Newcastle Disease Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Newcastle Disease Vaccine Sales (M Doses) Forecast by Application (2017-2022)
Figure EMEA Newcastle Disease Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources